Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance
Conclusion IND/GLY demonstrated a good long-term safety profile in a real-world setting in Japanese patients with COPD, with beneficial effects in terms of the lung function and symptoms in clinical use.PMID:34483208 | DOI:10.2169/internalmedicine.7845-21
Source: Internal Medicine - Category: Internal Medicine Authors: Chihiro Kato Hajime Yoshisue Noriko Nakamura Takayoshi Sasajima Source Type: research
More News: Cardiology | Cardiovascular | Chronic Obstructive Pulmonary | Cough | Drugs & Pharmacology | Heart | Internal Medicine | Japan Health